Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer


To further enhance the company's expertise in clinical oncology trials

Pharmatech, a Denver, Colorado, US-based specialist in CRO and SMO oncology services, has appointed Krystyna Kowalczyk as Chief Operating Officer to further enhance the company's focus and therapeutic expertise surrounding clinical oncology trials.

Sign up for your free email newsletter

Prior to joining Pharmatech, Kowalczyk was Executive Vice President of Clinical Operations at Novella Clinical. She has more than 25 years of experience as a clinical research professional and has a strong background in organisational development, financial management, corporate leadership, operational strategy, project management, and customer management in the CRO sector.